Historical record - last NADAC publication: 1/15/2019
Product Information
DIOVAN HCT 320-12.5 MG TAB is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.7935 per EA under NDC 00078047134. Its NADAC has been published 321 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the valsartan and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 320 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078047134
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/15/2019
Active Ingredients
HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
New Drug (NDA)
FDA Application
NDA020818On Market Since
4/28/2006
Pharmacological Classes
Price Statistics
The NADAC for DIOVAN HCT 320-12.5 MG TAB has been published 321 times since Nov 28, 2013, and over the history we have for it it has risen 119.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.7935 per EA |
|---|---|
| All-time high | $11.7935 (Jan 15, 2020) |
| All-time low | $5.3813 (Nov 28, 2013) |
| Median price | $8.7884 |
| Average price | $8.9454 |
| Largest weekly change | +21.5% (Mar 14, 2018) |
| Weeks tracked | 321 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DIOVAN HCT 320-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DIOVAN HCT 320-12.5 MG TAB, manufactured by Novartis Pharmaceuticals Corporation, is $11.7935 per EA (NDC 00078047134), effective Jan 15, 2020.
How has the price of DIOVAN HCT 320-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DIOVAN HCT 320-12.5 MG TAB has risen 119.2%. It has been tracked across 321 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DIOVAN HCT 320-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for DIOVAN HCT 320-12.5 MG TAB has ranged from a low of $5.3813 (Nov 28, 2013) to a high of $11.7935 (Jan 15, 2020), with a median of $8.7884 per EA.
Are there cheaper alternatives to DIOVAN HCT 320-12.5 MG TAB?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VALSARTAN-HYDROCHLOROTHIAZIDE 320-12.5 MG TAB, is $0.1934 per EA — about 98% below DIOVAN HCT 320-12.5 MG TAB.
Who manufactures DIOVAN HCT 320-12.5 MG TAB?
DIOVAN HCT 320-12.5 MG TAB (NDC 00078047134) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification